Clinical Trial Update: Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

View source ↗

Summary

This update reports long-term follow-up data for subjects treated with NTLA-2002 in hereditary angioedema, with ongoing enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• NTLA-2002 (NTLA-2002)

Snippet

Sponsor: Intellia Therapeutics | Conditions: Hereditary Angioedema | Status: ENROLLING_BY_INVITATION